GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Caliway Biopharmaceuticals Co Ltd (TPE:6919) » Definitions » Total Long-Term Liabilities

Caliway Biopharmaceuticals Co (TPE:6919) Total Long-Term Liabilities : NT$18.73 Mil (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Caliway Biopharmaceuticals Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Caliway Biopharmaceuticals Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was NT$18.73 Mil.

Caliway Biopharmaceuticals Co Total Long-Term Liabilities Historical Data

The historical data trend for Caliway Biopharmaceuticals Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliway Biopharmaceuticals Co Total Long-Term Liabilities Chart

Caliway Biopharmaceuticals Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial 116.00 28.57 20.46 11.87 20.95

Caliway Biopharmaceuticals Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.67 7.46 5.23 20.95 18.73

Caliway Biopharmaceuticals Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Caliway Biopharmaceuticals Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Caliway Biopharmaceuticals Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Caliway Biopharmaceuticals Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Caliway Biopharmaceuticals Co Ltd (TPE:6919) » Definitions » Total Long-Term Liabilities
Comparable Companies
TPE:6550 ROCO:4743 ROCO:6535 ROCO:4728 ROCO:4147 ROCO:6589 ROCO:6547 ROCO:6617 ROCO:6712 TPE:6541 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No.99, Sec. 1, Xintai 5th Road, 32rd Floor-9, Xizhi District, New Taipei City, TWN, 221
Website
https://www.caliway.com.tw
Caliway Biopharmaceuticals Co Ltd specializes in the development of new drugs for aesthetic medicine and chronic inflammation. Its pipeline candidates are CBL-514, CBA-539, and CBO-012.

Caliway Biopharmaceuticals Co Headlines

No Headlines